CTOs on the Move

MedAssets

www.medassets.com

 
For more than a decade, we’ve been challenging convention and helping push the healthcare industry forward. What drives us is a passion for improving healthcare. The specialized talents of our people reflect our passion. We employ approximately 3,300 men and women who advise, support and perform the core business operations of more than 4,500 hospitals and 123,000 non-acute healthcare providers. MedAssets is a performance improvement company focused on helping providers realize financial and operational gains so that they can sustainably serve the needs of their community. Our passion to help clients improve the quality and safety of care delivery is driven by ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $500M-1 Billion
  • www.medassets.com
  • 100 North Point Center, East, Suite 200
    Alpharetta, GA USA 30022
  • Phone: 678.323.2500

Executives

Name Title Contact Details

Similar Companies

Grief Recovery Institute

Grief Recovery Institute is a Sherman Oaks, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AdCare Hospital Worcester

AdCare Hospital Worcester is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Georgetown Animal Hospital

Georgetown Animal Hospital is a Hudsonville, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mercy Hospital of Portland

Mercy Hospital of Portland is a Portland, ME-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Signal Genetics

Signal Genetics is a commercial stage, molecular diagnostic company focused on providing innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer. The company was founded in April 2010 after becoming the exclusive licensee to the world-renowned research on multiple myeloma (MM) performed at the University of Arkansas for Medical Sciences (UAMS). Signal Genetics’ flagship product - MyPRS (Myeloma Prognostic Risk Signature) is based upon more than two decades of clinical research on nearly 10,000 MM patients who received their care at UAMS. Signal Genetics offer the MyPRS test out of its state-of-the-art, CLIA certified reference laboratory located in Little Rock, AR. The company is dedicated to making its extensively validated diagnostic services available to all patients who need them. The mission of Signal Genetics is to develop, validate and deliver innovative diagnostic services that enable better patient-care decisions.